Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 2001

View Archived Issues

IND filed for transmucosal pain relief product

Specific NSAIDs decrease beta-amyloid(1-42) in the brain

Arakis and Penwest form strategic alliance for oral pain management product development

New pivotal phase III studies begin for Alprox-TD in erectile dysfunction

Recruitment set to commence for NAVIGATOR, largest-ever diabetes prevention trial

Six-month results presented for CAT-152 following glaucoma and cataract surgery

Enrollment completed for phase IIb stroke study of UK-279276

InSite Vision initiates human clinical study of ISV-401 during Q3 2001

Development candidate for attention and cognitive disorders selected by NeoTherapeutics

Small-molecule Celgene/Serono IKK-2 inhibitors with disease-modifying antiarthritic activity

CDD-0304: a new lead tetrahydropyridyl-thiadiazole M1 agonist

Plant components under study for potential in Alzheimer's and Parkinson's disease

FDA approves Coreg for the treatment of severe heart failure

Nitrate compound GT-715 appears to represent new approach to neurodegenerative disease therapy

Antiasthmatic agent developed in Japan advances to clinical testing overseas

Japanese approval sought by Mochida for new DIC treatment

First in vivo data supporting selective inhibition of ERK1/2 in osteoarthritis therapy

Kineret cleared for U.S. marketing, extensively covered at ACR/ARHP meeting

GSK and Bayer sign worldwide copromotion agreement for vardenafil in erectile dysfunction

NIH awards two grants to Progenics for development of innovative HIV therapies

Start of phase II trial of NCX-4016 following presentation of promising preclinical data

Potential new anticoagulants in development at Sanofi-Synthelabo

Vertex invention provides p38 inhibitors, their production and use

Somatostatin sst3 receptor antagonists with anxiolytic profile prepared at Novartis

Improved taxane anticancer agents discovered during research at BMS

Axys identifies heterocyclic agents that inhibit factor Xa, factor VIIa and/or thrombin

New antitumor/antibacterial compounds isolated from Penicillium sp. in Japan

Joint French/Japanese research program yields new GSK3beta inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...